Kirkland, Washington-based Cardiac Dimensions, a developer of treatments for functional mitral regurgitation in patients with heart failure, has secured $17.5 million in Series C financing. The investors included Aperture Venture Partners, Arboretum Ventures, Hostplus, Life Sciences Partners, Lumira Ventures and M. H. Carnegie & Co.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: